KACI NEWLIN: Open Payments
NPI 1194333849 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 48 payments from 14 companies in 2025. Trend: 2023 $1,503 · 2024 $1,287 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 8 | $169 |
| Amgen Inc. | 7 | $132 |
| Fresenius USA Marketing, Inc. | 6 | $110 |
| Travere Therapeutics, Inc. | 4 | $77 |
| AKEBIA THERAPEUTICS INC | 4 | $76 |
| Calliditas Therapeutics US Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Vifor Pharma, Inc. | 2 | $47 |
Products named: Fabhalta, VELPHORO, Vafseo, TARPEYO, TAVNEOS, JYNARQUE, KRYSTEXXA, Vanrafia.
Industry payments across TN — which companies pay providers there.
